We are excited about combining the talent and experience of Boston Scientific and Guidant employees. We look forward to working with Guidant to complete the transaction quickly and to creating a global leader in cardiovascular devices.
Through this combination, Boston Scientific becomes more diversified, participating in two of the largest medical device markets - interventional cardiology and cardiac rhythm management.
Boston Scientific plans to implement all the recommendations that apply to manufacturers. In particular, we believe an industry-wide, independent committee of outside experts should be established.